Clinical trial
Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717)
NCT00281320 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00281320 |
|---|---|
| Title | Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) |
| Official title | A Randomized, Parallel Group, Multiple Dose, 6-Week Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Asenapine in Elderly Subjects With Psychosis. |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Psychosis |
| Intervention type | Drug |
| Interventions | Asenapine |
| Enrollment | 122 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 24, 2006 |
| Last update posted | Feb 9, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: